InflaRx N.V. (IFRX) DCF Valuation

InflaRx N.V. (IFRX) DCF Valuation
  • ✓ Totalmente Editável: Adapte-Se Às Suas Necessidades No Excel Ou Planilhas
  • ✓ Design Profissional: Modelos Confiáveis ​​E Padrão Da Indústria
  • ✓ Pré-Construídos Para Uso Rápido E Eficiente
  • ✓ Não É Necessária Experiência; Fácil De Seguir

InflaRx N.V. (IFRX) Bundle

DCF model
Get Full Bundle:
$25 $15
$12 $7
$12 $7
$12 $7
$12 $7
$12 $7
$12 $7
$12 $7
$12 $7

TOTAL:

Explore InflaRx N.V. (IFRX) financial prospects with our user-friendly DCF Calculator! Enter your predictions for growth, margins, and expenses to determine the intrinsic value of InflaRx N.V. (IFRX) and shape your investment approach.


Discounted Cash Flow (DCF) - (USD MM)

Year AY1
2019		 AY2
2020		 AY3
2021		 AY4
2022		 AY5
2023		 FY1
2024		 FY2
2025		 FY3
2026		 FY4
2027		 FY5
2028
Revenue .0 .0 .0 .0 .1 .1 .1 .1 .1 .1
Revenue Growth, % 0 0 0 0 0 0 0 0 0 0
EBITDA -59.2 -33.8 -48.8 -32.6 -46.7 .0 .0 .0 .0 .0
EBITDA, % 100 100 100 100 -71033.47 60 60 60 60 60
Depreciation .7 .7 .7 .6 .6 .1 .1 .1 .1 .1
Depreciation, % 100 100 100 100 899.97 100 100 100 100 100
EBIT -59.8 -34.5 -49.6 -33.2 -47.3 .0 .0 .0 .0 .0
EBIT, % 100 100 100 100 -71933.43 60 60 60 60 60
Total Cash 120.3 84.5 86.9 85.2 94.0 .1 .1 .1 .1 .1
Total Cash, percent .0 .0 .0 .0 .1 .0 .0 .0 .0 .0
Account Receivables .0 1.5 1.3 1.5 3.9
Account Receivables, % 100 100 100 100 6009.87
Inventories .0 .0 .0 .0 11.8 .1 .1 .1 .1 .1
Inventories, % 100 100 100 100 18018.68 100 100 100 100 100
Accounts Payable 12.9 8.6 1.8 5.2 12.5 .1 .1 .1 .1 .1
Accounts Payable, % 100 100 100 100 18980.11 100 100 100 100 100
Capital Expenditure -.6 -.1 .0 -.2 -.1 .0 .0 .0 .0 .0
Capital Expenditure, % 100 100 100 100 -128.55 -20 -20 -20 -20 -20
Tax Rate, % 0 0 0 0 0 0 0 0 0 0
EBITAT -55.9 -34.5 -49.6 -30.4 -47.3 .0 .0 .0 .0 .0
Depreciation
Changes in Account Receivables
Changes in Inventories
Changes in Accounts Payable
Capital Expenditure
UFCF -42.9 -39.7 -55.6 -26.7 -53.8 3.3 .1 .1 .1 .1
WACC, % 11.83 11.83 11.83 11.83 11.83 11.83 11.83 11.83 11.83 11.83
PV UFCF
SUM PV UFCF 3.2
Long Term Growth Rate, % 2.00
Free cash flow (T + 1) 0
Terminal Value 1
Present Terminal Value 1
Enterprise Value 4
Net Debt -12
Equity Value 16
Diluted Shares Outstanding, MM 55
Equity Value Per Share 0.29

What You Will Receive

  • Authentic IFRX Financial Data: Pre-loaded with InflaRx N.V.’s historical and projected figures for accurate analysis.
  • Completely Customizable Template: Easily adjust key inputs such as revenue growth, WACC, and EBITDA %.
  • Instant Calculations: Watch as InflaRx N.V.’s intrinsic value updates in real-time according to your modifications.
  • Expert Valuation Tool: Tailored for investors, analysts, and consultants aiming for precise DCF outcomes.
  • Intuitive Design: Streamlined layout and straightforward instructions suitable for all skill levels.

Key Features

  • Comprehensive Financial Data: Gain access to precise pre-loaded historical financials and future forecasts for InflaRx N.V. (IFRX).
  • Adjustable Forecast Parameters: Modify highlighted cells for key metrics such as WACC, growth rates, and profit margins.
  • Real-Time Calculations: Enjoy automatic updates for DCF, Net Present Value (NPV), and cash flow evaluations.
  • User-Friendly Dashboard: View clear charts and summaries to effectively interpret your valuation findings.
  • Designed for All Skill Levels: A straightforward, intuitive layout tailored for investors, CFOs, and consultants alike.

How It Works

  • 1. Access the Model: Download and open the Excel file containing InflaRx N.V.'s (IFRX) financial data.
  • 2. Adjust Inputs: Modify essential variables such as revenue growth, discount rates, and operating expenses.
  • 3. Analyze Results: The DCF model automatically computes the intrinsic value and net present value (NPV).
  • 4. Explore Scenarios: Evaluate various projections to understand different valuation possibilities.
  • 5. Make Informed Decisions: Share detailed valuation analysis to enhance your investment strategies.

Why Choose InflaRx N.V. (IFRX)?

  • Innovative Solutions: Cutting-edge therapies developed for serious inflammatory diseases.
  • Proven Track Record: Backed by robust clinical data demonstrating efficacy and safety.
  • Dedicated Team: Experienced professionals committed to advancing patient care.
  • Strong Pipeline: A diverse range of candidates in various stages of development.
  • Collaborative Approach: Partnerships with leading institutions to enhance research and development.

Who Should Use This Product?

  • Investors: Evaluate InflaRx N.V. (IFRX) for informed stock trading decisions.
  • CFOs and Financial Analysts: Optimize valuation assessments and validate financial forecasts.
  • Biotech Entrepreneurs: Understand the valuation methods applied to companies like InflaRx N.V. (IFRX).
  • Consultants: Provide comprehensive valuation analyses and reports for clients in the biotech sector.
  • Students and Educators: Utilize current market data to learn and teach valuation practices in biotechnology.

What the Template Contains

  • Operating and Balance Sheet Data: Pre-filled InflaRx N.V. (IFRX) historical data and forecasts, including revenue, EBITDA, EBIT, and capital expenditures.
  • WACC Calculation: A dedicated sheet for Weighted Average Cost of Capital (WACC), including parameters like Beta, risk-free rate, and share price.
  • DCF Valuation (Unlevered and Levered): Editable Discounted Cash Flow models showing intrinsic value with detailed calculations.
  • Financial Statements: Pre-loaded financial statements (annual and quarterly) to support analysis.
  • Key Ratios: Includes profitability, leverage, and efficiency ratios for InflaRx N.V. (IFRX).
  • Dashboard and Charts: Visual summary of valuation outputs and assumptions to analyze results easily.

No products were found matching.